{"data":{"type":"company_profile","id":83991,"entity_id":"wefunder:company:83991","attributes":{"canonical_url":"https://wefunder.com/entelexo","generated_at":"2026-06-23T00:50:41Z","updated_at":"2026-06-22T05:03:19Z","entity_ids":{"company":"wefunder:company:83991","slug":"wefunder:company_slug:entelexo"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-23T00:50:41Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:50:41Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:50:41Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T00:50:41Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T00:50:41Z","confidence":"medium"}}},"company":{"id":83991,"entity_id":"wefunder:company:83991","slug":"entelexo","name":"Entelexo (YC W21)","tagline":"Creating a new class of drugs to address incurable autoimmune diseases","elevator_pitch":"We are applying new knowledge of stem cell biology to develop new treatments for autoimmune diseases.","location":"Irvine, CA","website":"https://www.entelexo.com/","total_amount_raised":32890,"total_investors":80,"is_funded":true,"is_active":true,"quality_score":3,"related_urls":["https://wefunder.com/entelexo","https://www.entelexo.com/"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/83991/xxl_cropped_p8emcqe91kxkz5otex38.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/83991/large_cropped_Screen_Shot_2021-04-01_at_9.16.16_PM.png","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/83991/standard_cropped_p8emcqe91kxkz5otex38.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/83991/standard_cropped_p8emcqe91kxkz5otex38.jpg","profile_video_url":"https://wefunder.wistia.com/medias/cor5bh7yr5"},"links":{"company_url":"https://www.entelexo.com/"},"highlights":[],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"\u0026gt;$1M raised to date, plus $310k on the same terms"},{"index":2,"claim_id":"claim-fact-2","value":"CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease"},{"index":3,"claim_id":"claim-fact-3","value":"Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year"},{"index":4,"claim_id":"claim-fact-4","value":"Our intellectual property is patent-protected (patent owned by the Company)"},{"index":5,"claim_id":"claim-fact-5","value":"Raising $2M for pre-clinical product development and IND enabling animal studies"}],"team":[{"id":1621013,"entity_id":"wefunder:company_role:1621013","user_entity_id":"wefunder:user:1447331","role":"founder","name":"Milad Riazifar","title":"CEO","bio":"Exosome biologist with 10+ years of experience in exosome research and clinical development. Led the first clinical trial using exosomes in autoimmune disease to treat Type 1 Diabetes.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/1621013/square_cropped_Screen_Shot_2021-04-01_at_9.34.50_PM.jpg?1624403606","profile_url":"https://wefunder.com/milad.riazifar","linkedin_url":"https://www.linkedin.com/in/miladriazifar/","related_urls":["https://wefunder.com/milad.riazifar"]},{"id":1621017,"entity_id":"wefunder:company_role:1621017","user_entity_id":"wefunder:user:1409148","role":"founder","name":"Todd Schurr","title":"COO","bio":"Multidisciplinary engineer with biomanufacturing experience. His expertise in cGMP manufacturing and process automation are key to streamlining the regulatory approval process.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/1621017/square_cropped_Screen_Shot_2021-04-01_at_9.35.04_PM.jpg?1620762333","profile_url":"https://wefunder.com/toddschurr","personal_url":"","linkedin_url":"https://www.linkedin.com/in/todd-schurr/","related_urls":["https://wefunder.com/toddschurr",""]},{"id":1629893,"entity_id":"wefunder:company_role:1629893","user_entity_id":"wefunder:user:1409240","role":"founder","name":"Cameron Taylor","title":"CTO","bio":"Biomedical engineer with extensive experience in stem cell biology and protein engineering. His expertise in gene editing is key to the development of the technology platform.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/1629893/square_cropped_Screen_Shot_2021-04-05_at_10.11.48_AM.jpg?1617643597","profile_url":"https://wefunder.com/camerontaylor3","linkedin_url":"https://www.linkedin.com/in/cameron-taylor-448b5a130/","related_urls":["https://wefunder.com/camerontaylor3"]}],"featured_investors":[{"id":5276,"entity_id":"wefunder:company_investor_profile:5276","investor_profile_id":46350,"investor_profile_entity_id":"wefunder:investor_profile:46350","subject_entity_id":"wefunder:user:12801","name":"Nate Lipscomb","bio":"Investor in mission-driven early stage startups, including Juni Learning, Orbillion Bio, NewZip, Caribou Biosciences, Recover, and AN2 Therapeutics.","avatar_url":"http://uploads.wefunder.com/uploads/user/avatar/12801/medium_blob.jpg","profile_url":"https://wefunder.com/nate.lipscomb","investment_total":20000,"investment_info":"Invested $20,000 this round","is_lead_investor":true,"related_urls":["https://wefunder.com/nate.lipscomb"]}],"investor_memos":[],"tab_counts":{"posts":0,"ask_questions":5,"featured_investors":1,"faq_entries":0},"active_fundraises":[{"id":44491,"entity_id":"wefunder:fundraise:44491","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":20000.0,"funding_started_at":"2021-06-24T10:30:02Z","funding_closed_at":"2021-07-28T05:04:33Z","auto_close_at":"2021-07-28T03:59:59Z"},{"id":44492,"entity_id":"wefunder:fundraise:44492","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"equity","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":500000.0,"funding_started_at":"2021-04-02T04:46:57Z"}],"latest_fundraise":{"id":44491,"entity_id":"wefunder:fundraise:44491","state":"successful","offering_type":"4(a)(6)","structure":"safe","testing_the_waters":false,"can_invest_now":false,"funding_started_at":"2021-06-24T10:30:02Z","funding_closed_at":"2021-07-28T05:04:33Z","terms":{"eb":null,"nb":"$15M","txt":"valuation cap"}},"recent_posts":[],"q_and_a":[{"id":140956,"entity_id":"wefunder:comment:140956","question":"Hello, what will happen if you don't raise your full amount? which what BTW?","author_name":"James Scott","votes":1,"created_at":"2021-04-10T14:52:23Z","canonical_url":"https://wefunder.com/entelexo#question-140956","answers":[]},{"id":191090,"entity_id":"wefunder:comment:191090","question":"I have real interest in this technology. What do you mean by address incurable autoimmune diseases? What does address mean if its incurable?","author_name":"Arthur Pallister","votes":0,"created_at":"2022-02-04T11:04:53Z","canonical_url":"https://wefunder.com/entelexo#question-191090","answers":[]},{"id":159472,"entity_id":"wefunder:comment:159472","question":"Are you responding to questions? I find them pertinent to investment disclosures.","author_name":"Chad L. Forester","votes":0,"created_at":"2021-07-22T19:46:08Z","canonical_url":"https://wefunder.com/entelexo#question-159472","answers":[]},{"id":154922,"entity_id":"wefunder:comment:154922","question":"How is the IP rights around your invention? And how stable are this type of compounds?","author_name":"Mads Georgsen","votes":0,"created_at":"2021-06-26T18:21:43Z","canonical_url":"https://wefunder.com/entelexo#question-154922","answers":[]},{"id":154758,"entity_id":"wefunder:comment:154758","question":"When will you work on ulcerative colitis?","author_name":"Tim Moss","votes":0,"created_at":"2021-06-24T16:45:08Z","canonical_url":"https://wefunder.com/entelexo#question-154758","answers":[]}],"faq":[]}}}